Consumer Products
Health And Wellness
Biotechnology
PolarityTE
$6.619876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-0.60%) Today
-$0.02 (-0.30%) After Hours
Why Robinhood?
You can buy or sell PolarityTE and other stocks, options, ETFs, and crypto commission-free!
About
PolarityTE, Inc. Common Stock, also called PolarityTE, is a commercial-stage biotechnology and regenerative biomaterials company, which focuses on discovering, designing and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Read More Its products include SkinTE, OsteoTE and Real Time Assistant. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.
Employees
156
Headquarters
Salt Lake City, Utah
Founded
1998
Market Cap
144.20M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
533.38K
High Today
$6.89
Low Today
$6.48
Open Price
$6.73
Volume
137.13K
52 Week High
$41.22
52 Week Low
$6.30
Collections
Consumer Products
Health And Wellness
Biotechnology
Medical
Engineering
Retail
Health
US
News
Seeking AlphaMay 23
PolarityTE: All Or Nothing
I attended two medical conferences where PolarityTE presented to potential customers. They seemed very interested, but want more trials. The company has provided updates on research and commercialization. The former is going well; the latter, very slowly. The company's competition for its first commercial product, SkinTE, is the current standard of care for severe burns and wounds: split-thickness skin grafts. There are many reasons they are awful. PolarityTE Bull(ets) PolarityTE (NASDAQ:PTE) is a two-y...
Seeking AlphaMay 10
PolarityTE, Inc. CEO Denver Lough on Q1 2019 Results - Earnings Call Transcript
PolarityTE, Inc. (NASDAQ:PTE) Q1 2019 Results Earnings Conference Call May 10, 2019 8:00 AM ET Company Participants Rich Haerle - Vice President, Investor Relations and Corporate Strategy Denver Lough - Chairman, Chief Executive Officer and Chief R&D Officer Richard Hague - Chief Operating Officer Matt Kemp - Chief Commercial Officer Nikolai Sopko - Chief Scientific Officer and Vice President, R&D Paul Mann - Chief Financial Officer Conference Call Participants Joshua Schimmer - Evercore ISI Kevin...
Price Paid on Robinhood
51% Lower
Right Now
52 Week Low
$6.30
Average Price Paid
$13.50
52 Week High
$41.22
Earnings
-$2.13
-$1.62
-$1.11
-$0.60
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$1.07 per share
Actual
-$1.18 per share